SANDERCOCK BRETT (Chief Financial Officer) sold 1.1% of their position (1K shares) of RESMED INC on the open market
Open‑market sale worth $241.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2026ACC: 0000943819-26-000002
Officer· Chief Financial Officer
Since Mar 2026
-1K
Net shares
Net seller
$241.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1K disposed
Non-Derivative Transactions1
ResMed Common Stock
Direct
Shares
−1K
Price / share
$241.75
Trade value
$241.75K
% of position
1.1%
1/2/2026
87.50K→86.50K
Total
Net shares
−1K
Net value
-$241.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 1/2/2026 | S · Sale | −1K | $241.75 | $241.75K | 1.1% | 87.50K | 86.50K |
| Total | −1K | -$241.75K | ||||||
Derivative Transactions0
No derivative transactions reported